Dr. Reddys Labs (RDY) Misses Q1 EPS by 89c

Dr. Reddys Labs (NYSE: RDY) reported Q1 EPS of ($0.28), $0.89 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $0 versus the consensus estimate of $742.49 million.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• RBC Capital Resumes BorgWarner (BWA) at Outperform
• JPMorgan Downgrades Li Ning Co. Ltd. (2331:HK) (LNNGF) to Neutral